Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels |
|---|---|---|---|
| 1 | |||
| Hot flush | 79% | x | |
| Sleep disturbance | 44.4% | x | |
| Pain | 30.9% | x | |
| Breast enlargement | 29.6% | x | |
| Breast pain | 19.8% | x | |
| Nipple tenderness | 19.8% | x | |
| Back pain | 17.3% | x | |
| Constipation | 14.8% | x | |
| Oedema peripheral | 14.8% | x | |
| Dizziness | 12.3% | x | |
| Headache | 12.3% | x | |
| Upper respiratory tract infection | 12.3% | x | |
| Diarrhoea | 11.1% | x | |
| Dysuria | 9.88% | x | |
| Fatigue | 9.88% | x | |
| Nausea | 9.88% | x | |
| Pollakiuria | 9.88% | x | |
| Urinary tract infection | 9.88% | x | |
| Urinary retention | 9.88% | x | |
| Hypersensitivity | x | ||
| Serum triglycerides increased | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | ||
|---|---|---|---|
| Prostate cancer | x | ||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |